MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine - PubMed (original) (raw)
MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine
M E Wolf et al. J Neurosci. 1994 Mar.
Abstract
Behavioral sensitization to psychomotor stimulants has been shown to be accompanied by a number of alterations in the mesoaccumbens dopamine (DA) system, including DA autoreceptor subsensitivity in the ventral tegmental area (VTA), postsynaptic D1 receptor supersensitivity in the nucleus accumbens (NAc), and augmentation of the DA-releasing effects of stimulants in the NAc. The present study examined whether coadministration of the noncompetitive NMDA antagonist MK-801 with amphetamine, which has been shown to prevent the development of behavioral sensitization to amphetamine, would also prevent these changes in mesoaccumbens DA function. Rats were treated for 5 d with amphetamine according to a regimen known to produce lasting sensitization. Extracellular single-unit recordings from VTA DA neurons in amphetamine-treated rats, performed after 1 d of abstinence, revealed robust autoreceptor subsensitivity to DA agonists. This was prevented in rats coadministered MK-801 with amphetamine during the 5 d pretreatment period. Recordings from NAc neurons in amphetamine-treated rats demonstrated supersensitivity of D1 receptors to iontophoretic administration of selective agonists when tested after 7 d of abstinence. This was also prevented by MK-801 coadministration. Microdialysis studies performed in awake rats after 7 d of abstinence failed to demonstrate augmentation of amphetamine-stimulated DA release in amphetamine-treated rats as compared to water controls, despite the fact that behavioral sensitization was evident in the former group during microdialysis experiments. MK-801 coadministration prevented behavioral sensitization in microdialysis rats but did not alter amphetamine-stimulated DA release. These results suggest (1) NMDA receptor stimulation is required for the development of both autoreceptor subsensitivity in the VTA and postsynaptic D1 receptor supersensitivity in the NAc during repeated amphetamine treatment, (2) these functional changes therefore appear to be closely associated with the development of behavioral sensitization, and (3) a dissociation can be demonstrated between the intensity of amphetamine-stimulated behavioral responses and amphetamine-stimulated DA release in the NAc.
Similar articles
- MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens.
Wolf ME, Xue CJ, White FJ, Dahlin SL. Wolf ME, et al. Brain Res. 1994 Dec 15;666(2):223-31. doi: 10.1016/0006-8993(94)90776-5. Brain Res. 1994. PMID: 7882032 - Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization.
Wolf ME, White FJ, Nassar R, Brooderson RJ, Khansa MR. Wolf ME, et al. J Pharmacol Exp Ther. 1993 Jan;264(1):249-55. J Pharmacol Exp Ther. 1993. PMID: 8093727 - Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
Mathé JM, Nomikos GG, Schilström B, Svensson TH. Mathé JM, et al. J Neurosci Res. 1998 Mar 1;51(5):583-92. doi: 10.1002/(SICI)1097-4547(19980301)51:5<583::AID-JNR5>3.0.CO;2-B. J Neurosci Res. 1998. PMID: 9512002 - The role of MK-801 in sensitization to stimulants.
Sripada S, Gaytan O, Swann A, Dafny N. Sripada S, et al. Brain Res Brain Res Rev. 2001 Apr;35(2):97-114. doi: 10.1016/s0165-0173(00)00046-1. Brain Res Brain Res Rev. 2001. PMID: 11336778 Review. - Parallel roles for dopamine in pathological gambling and psychostimulant addiction.
Zack M, Poulos CX. Zack M, et al. Curr Drug Abuse Rev. 2009 Jan;2(1):11-25. doi: 10.2174/1874473710902010011. Curr Drug Abuse Rev. 2009. PMID: 19630734 Review.
Cited by
- Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex.
Baldwin AE, Sadeghian K, Kelley AE. Baldwin AE, et al. J Neurosci. 2002 Feb 1;22(3):1063-71. doi: 10.1523/JNEUROSCI.22-03-01063.2002. J Neurosci. 2002. PMID: 11826135 Free PMC article. - Balanced NMDA receptor activity in dopamine D1 receptor (D1R)- and D2R-expressing medium spiny neurons is required for amphetamine sensitization.
Beutler LR, Wanat MJ, Quintana A, Sanz E, Bamford NS, Zweifel LS, Palmiter RD. Beutler LR, et al. Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4206-11. doi: 10.1073/pnas.1101424108. Epub 2011 Feb 22. Proc Natl Acad Sci U S A. 2011. PMID: 21368124 Free PMC article. - Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior.
Fischer KD, Knackstedt LA, Rosenberg PA. Fischer KD, et al. Neurochem Int. 2021 Mar;144:104896. doi: 10.1016/j.neuint.2020.104896. Epub 2020 Nov 5. Neurochem Int. 2021. PMID: 33159978 Free PMC article. Review. - AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine.
Wolf ME, Ferrario CR. Wolf ME, et al. Neurosci Biobehav Rev. 2010 Nov;35(2):185-211. doi: 10.1016/j.neubiorev.2010.01.013. Epub 2010 Jan 28. Neurosci Biobehav Rev. 2010. PMID: 20109488 Free PMC article. Review. - The dopamine D1-D2 receptor heteromer exerts a tonic inhibitory effect on the expression of amphetamine-induced locomotor sensitization.
Shen MY, Perreault ML, Fan T, George SR. Shen MY, et al. Pharmacol Biochem Behav. 2015 Jan;128:33-40. doi: 10.1016/j.pbb.2014.11.011. Epub 2014 Nov 13. Pharmacol Biochem Behav. 2015. PMID: 25444866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources